Top Markets
#1 Black Phoenix Black Phoenix +356.69%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +62.32%
#4 Gold Park Gold Park +57.04%
#5 Acurast Acurast +36.39%
#6 OpenEden OpenEden +29.86%
#7 BasedHype BasedHype +26.83%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.30%
#9 Cryptopia Cryptopia +21.54%
#10 Wibx Wibx +16.66%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUS
Rang in Aktien #40780
Lotus Pharmaceuticals, Inc. currently has no substantial business activities.... Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Aktienkurs
$0.003
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$82.31K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-62.64%
Land
US
Handel Lotus Pharmaceuticals, Inc. (LTUS)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Lotus Pharmaceuticals, Inc. (LTUS)
Dividendenrendite (TTM) von Lotus Pharmaceuticals, Inc. (Aktienkürzel: LTUS) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Lotus Pharmaceuticals, Inc. (LTUS) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.56%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US